#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins | The Peter Attia Drive

This episode explores SGLT2 inhibitors' effectiveness in type 2 diabetes, touching on history, benefits, mechanism of action, and risk reductions. Turning the attention to statins, it unravels the connection between these drugs and insulin resistance.

Outlines

Sign in to continue reading, translating and more.

Open full episode in Podwise

#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins

The Peter Attia Drive

AMA 53 Sneak Peek: Metabolic Health and Statins

SGLT2 Inhibitors and Statins: A Comprehensive Overview

SGLT2 Inhibitors: A Novel Approach to Managing Type 2 Diabetes

From Natural Substances to SGLT2 Inhibitors: A Journey of Drug Development

SGLT2 Inhibitors: Benefits, Differences, and Comparison with Metformin

SGLT2 Inhibitors: Beyond Glycemic Control

SGLT2 Inhibitors: A Promising Therapeutic Avenue

Premium Membership Benefits and Podcast Disclaimer

#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins

The Peter Attia Drive

00:10AMA 53 Sneak Peek: Metabolic Health and Statins

AMA 53 Sneak Peek: Metabolic Health and Statins

03:53SGLT2 Inhibitors and Statins: A Comprehensive Overview

SGLT2 Inhibitors and Statins: A Comprehensive Overview

06:23SGLT2 Inhibitors: A Novel Approach to Managing Type 2 Diabetes

SGLT2 Inhibitors: A Novel Approach to Managing Type 2 Diabetes

10:05From Natural Substances to SGLT2 Inhibitors: A Journey of Drug Development

From Natural Substances to SGLT2 Inhibitors: A Journey of Drug Development

14:30SGLT2 Inhibitors: Benefits, Differences, and Comparison with Metformin

SGLT2 Inhibitors: Benefits, Differences, and Comparison with Metformin

18:10SGLT2 Inhibitors: Beyond Glycemic Control

SGLT2 Inhibitors: Beyond Glycemic Control

21:30SGLT2 Inhibitors: A Promising Therapeutic Avenue

SGLT2 Inhibitors: A Promising Therapeutic Avenue

24:04Premium Membership Benefits and Podcast Disclaimer

Premium Membership Benefits and Podcast Disclaimer